Supply Chain Latest News news and information

China will punish 39 hospital employees for taking illegal kickbacks from drugmakers amid a widening investigation of corruption in the country's $350 billion healthcare market.
FULL STORY »

The average prices paid for linear accelerators, which use radiation to treat patients with cancer, rose 20% from April to May, in part because of more hospitals buying highly configured systems, according to the latest Modern Healthcare/ECRI Institute Technology Price Index.
FULL STORY »

A new regulation will allow certain hospitals to buy orphan drugs at deeply discounted prices if they're used to treat non-orphan conditions or diseases.
FULL STORY »

Bolstered by a high-profile legal victory at the U.S. Supreme Court this spring, the Federal Trade Commission has made the blocking of “pay-for-delay” settlements by drug companies one of its highest priorities—even reviewing older settlements to see if retroactive enforcement is...
FULL STORY »

U.S. health regulators are cracking down on 15 companies for selling products they said falsely claim to cure or mitigate the symptoms of diabetes.
FULL STORY »

Executives at GlaxoSmithKline were warned nearly two years ago about critical problems with the way the company conducted research at its drug development center in China.
FULL STORY »

Falling patient volume at hospitals has depressed the earnings not only of healthcare providers but also of the laboratory, diagnostic and medical device companies that work with them.
FULL STORY »

The British pharmaceutical giant GlaxoSmithKline said that some of its executives might have broken the law in China, the company’s strongest statement yet on a bribery and corruption scandal that has engulfed its China operations.
FULL STORY »

Intuitive Surgical slashed its forecast for sales growth this year as the company deals with increasing and concerns about its da Vinci surgical robot systems.
FULL STORY »

The former top two executives of an Austin, Texas, medical-device company have been accused of defrauding shareholders and investors out of $400 million.
FULL STORY »